A200230 logo

TELCON RF PHARMACEUTICAL. Inc. Stock Price

KOSDAQ:A200230 Community·₩35.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A200230 Share Price Performance

₩996.00
-960.67 (-49.10%)
₩996.00
-960.67 (-49.10%)
Price ₩996.00

A200230 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

2 Risks
0 Rewards

TELCON RF PHARMACEUTICAL. Inc. Key Details

₩43.7b

Revenue

₩32.0b

Cost of Revenue

₩11.6b

Gross Profit

₩45.1b

Other Expenses

-₩33.5b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-929.50
26.65%
-76.71%
31.4%
View Full Analysis

About A200230

Founded
1999
Employees
124
CEO
Jin-Hun Lim
WebsiteView website
www.telcon.co.kr

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.

Recent A200230 News & Updates

Recent updates

No updates